RXL:NYE-ProShares Ultra Health Care (USD)

ETF | Trading--Leveraged Equity |

Last Closing

USD 39.9355

Change

-1.72 (-4.14)%

Market Cap

N/A

Volume

7.66K

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-04-21 )

Largest Industry Peers for Trading--Leveraged Equity

Symbol Name Price(Change) Market Cap
SOXL Direxion Daily Semiconductor B..

-0.49 (-5.33%)

USD 8.14B
QLD ProShares Ultra QQQ

-3.80 (-4.89%)

USD 5.50B
SSO ProShares Ultra S&P500

-3.41 (-4.75%)

USD 4.33B
FNGU MicroSectors FANG+ Index 3X Le..

N/A

USD 4.29B
UPRO ProShares UltraPro S&P500

-4.14 (-7.10%)

USD 2.91B
TECL Direxion Daily Technology Bull..

-3.40 (-7.84%)

USD 1.95B
YINN Direxion Daily FTSE China Bull..

-0.07 (-0.25%)

USD 1.19B
USD ProShares Ultra Semiconductors

-2.19 (-6.68%)

USD 0.61B
UDOW ProShares UltraPro Dow30

-5.13 (-7.52%)

USD 0.56B
LABU Direxion Daily S&P Biotech Bul..

-0.90 (-1.91%)

USD 0.53B

ETFs Containing RXL

KGHG 4.13 % 0.00 %

N/A

N/A
IEUS iShares MSCI Europe Small.. 0.00 % 0.40 %

-0.14 (0%)

USD 0.10B
SCZ iShares MSCI EAFE Small-C.. 0.00 % 0.39 %

+0.04 (+0%)

USD 9.26B
LGWU:F Lyxor Index Fund - Lyxor .. 0.00 % 0.00 %

N/A

N/A
ZPRX:F SSgA SPDR ETFs Europe II .. 0.00 % 0.00 %

N/A

USD 0.21B
ZPRX:XETRA SPDR® MSCI Europe Small .. 0.00 % 0.00 %

N/A

N/A
1388:TSE 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Trading--Leveraged Equity) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -9.21% 67% D+ 40% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -9.21% 67% D+ 38% F
Trailing 12 Months  
Capital Gain -14.95% 48% F 22% F
Dividend Return 1.28% 77% C+ 25% F
Total Return -13.67% 46% F 21% F
Trailing 5 Years  
Capital Gain 42.97% 43% F 55% F
Dividend Return 4.52% 27% F 8% B-
Total Return 47.49% 40% F 45% F
Average Annual (5 Year Horizon)  
Capital Gain 8.36% 29% F 64% D
Dividend Return 8.74% 28% F 59% D-
Total Return 0.39% 23% F 10% F
Risk Return Profile  
Volatility (Standard Deviation) 29.03% 97% N/A 34% F
Risk Adjusted Return 30.12% 50% F 46% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.